Portions of this exhibit marked [*] are requested to be treated confidentially. LICENSE AGREEMENTLicense Agreement • November 14th, 2007 • Innovive Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • England
Contract Type FiledNovember 14th, 2007 Company Industry JurisdictionTMRC Co., Ltd., a corporation organized under the laws of Japan (“TMRC”), having a place of business at 4-3, Akasaka 3-chome, Minato-ku, Tokyo, Japan
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. LICENSE AGREEMENTLicense Agreement • March 21st, 2007 • Innovive Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • England
Contract Type FiledMarch 21st, 2007 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”) dated as of December 6, 2006 (the “Effective Date”) is entered into between TMRC CO., LTD., a privately-held corporation organized under the laws of Japan (“TMRC”), having a place of business at 4-3 Akasaka, 3-chome, Minato-ku, Tokyo 107-0052, Japan and INNOVIVE PHARMACEUTICALS, INC., a corporation organized under the laws of the State of Delaware, U.S.A. (“Innovive”), having a place of business at 555 Madison Avenue, New York, NY 10022, U.S.A.